<?xml version="1.0" encoding="UTF-8"?>
<p>Health related quality of life assessment revealed no differences between the study groups on the EORTC QLQ-C 30 questionnaire in a RCT with patients with multiple myeloma undergoing high dose chemotherapy and autologous stem cell transplantation (verum: 
 <italic>Agaricus blazei Murill</italic>) (
 <xref rid="B50" ref-type="bibr">Tangen et al., 2015</xref>).
</p>
